Manufacturing and Production

Showing 15 posts of 5860 posts found.

alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …
giovanni_caforio

Giovanni Caforio to be made chairman of the board at BMS

January 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Giovanni Caforio, bristol myers-squibb

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …

Biogen’s gains late-year drug approval first for controversially expensive drug

January 3, 2017 Manufacturing and Production, Sales and Marketing Biogen, FDA

The FDA squeezed in one last approval before the year ended with the first approval for a drug to treat …
seattle_genetics

Four die in Seattle Genetics’ drug trial

January 3, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Seattle Genetics, patient deaths, trial hold

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …

Sanofi files lawsuit against Novo Nordisk over ‘false allegations’

January 3, 2017 Manufacturing and Production, Sales and Marketing Novo Nordisk, Sanofi

Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the …
handshake

Sanofi and Boehringer confirm successful exchange of businesses

January 3, 2017 Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Sanofi

Sanofi and Boehringer Ingelheim have confirmed the successful completion of the exchange of Sanofi’s animal health business (Merial, based in …

Mylan ends 2016 with spate of generics

January 3, 2017 Manufacturing and Production, Sales and Marketing Mylan, generics, launch

Mylan ended a difficult year for itself by releasing a rash of generics into the market, ending the year strongly …
merrimack-pharmaceuticals

Merrimack’s breast cancer trial stutters to halt

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …
frederik_wilkinson

Impax Laboratories parts with CEO

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Impax Laboratories

Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …
2017

Seven pharma trends for 2017

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …
novonordiskhq

Fluor wins $2 billion Novo contract to build API manufacturing facility

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fluor, Novo Nordisk, north carolina

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …
jj_2johnson_and_johnson

Actelion acquisition hokey-cokey continues with J&J returning to table

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …
sun_pharma

Sun Pharma to acquire Novartis’s drug for $175 million

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

Japan announces measure to crack down on drug pricing

December 20, 2016 Manufacturing and Production, Medical Communications Japan, Shinzo Abe, opdivo

Japan has committed to annual drug price reviews whilst also expanding the scope by which the prices are deemed to …
The Gateway to Local Adoption Series

Latest content